[Myocardial infarction in patients with hypertension].
Kido
Shinsuke
S
First Department of Internal Medicine, Asahikawa Medical College.
Hasebe
Naoyuke
N
Kikuchi
Kenjiro
K
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D052279:Creatine Kinase, MB Form; D004452:Echocardiography; D004562:Electrocardiography; D006801:Humans; D006973:Hypertension / Q000150:complications*; D007527:Isoenzymes / Q000097:blood; D009203:Myocardial Infarction / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D015425:Myocardial Reperfusion; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D007527:Isoenzymes; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form; D001241:Aspirin